|
158
|
553
|
5vqsA |
Crystal structure of hiv-1 reverse transcriptase in complex with n-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-4-methylnaphthalen-1-yl)acrylamide (jlj685), a non-nucleoside inhibitor |
|
111
|
424
|
5vqvB |
Crystal structure of hiv-1 reverse transcriptase (y181c) variant in complex with n-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-4-methylnaphthalen-1-yl)-n-methylacrylamide (jlj684), a non-nucleoside inhibitor |
|
113
|
424
|
5vqxB |
Crystal structure of hiv-1 reverse transcriptase (y181c) variant in complex with 2-chloro-n-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-4-methylnaphthalen-1-yl)-n-methylacetamide (jlj686), a non-nucleoside inhibitor |
|
109
|
424
|
5vqrB |
Crystal structure of hiv-1 reverse transcriptase in complex with n-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-4-methylnaphthalen-1-yl)-n-methylacrylamide (jlj684), a non-nucleoside inhibitor |
|
154
|
554
|
5vqxA |
Crystal structure of hiv-1 reverse transcriptase (y181c) variant in complex with 2-chloro-n-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-4-methylnaphthalen-1-yl)-n-methylacetamide (jlj686), a non-nucleoside inhibitor |
|
113
|
424
|
5vqzB |
Crystal structure of hiv-1 reverse transcriptase (k103n, y181c) variant in complex with 2-chloro-n-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-4-methylnaphthalen-1-yl)-n-methylacetamide (jlj686), a non-nucleoside inhibitor |
|
113
|
424
|
5vquB |
Crystal structure of hiv-1 reverse transcriptase (y181c) variant in complex with n-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-4-methylnaphthalen-1-yl)-2-fluoro-n-methylacetamide (jlj683), a non-nucleoside inhibitor |
|
17
|
99
|
5vckA |
Hiv protease (pr) with tl-3 in the active site and (z)-n-(thiazol-2-yl)-n'-tosylcarbamimidate in the exosite |
|
17
|
99
|
5veaA |
Hiv protease (pr) with tl-3 in active site and 4-methylbenzene-1,2-diamine in exosite |
|
0
|
10
|
5v5mE |
Crystal structure of hla-b*5701 complex with hiv-1 gag derived peptide tw10 |
|
0
|
10
|
5v5lE |
Crystal structure of hla-b*5801 complex with hiv-1 gag derived peptide tw10 |
|
19
|
99
|
5upzA |
Hiv-1 wild type protease with grl-0518a , an isophthalamide-derived p2-p3 ligand with the para-hydoxymethyl sulfonamide isostere as the p2' group |
|
18
|
99
|
5upjA |
Hiv-2 protease/u99283 complex |
|
18
|
99
|
5ultA |
Hiv-1 wild type protease with grl-100-13a (a crown-like oxotricyclic core as the p2-ligand with the sulfonamide isostere as the p2' group) |
|
19
|
99
|
5uovA |
Hiv-1 wild type protease with grl-1118a , an isophthalamide-derived p2-p3 ligand with the sulfonamide isostere as the p2' group |
|
16
|
99
|
5ufzA |
Hiv-1 protease complexed with inhibitor: (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl [(1s,2s)-1-(1-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}cyclopropyl)-1-hydroxy-3-phenylpropan-2-yl]carbamate |
|
111
|
424
|
5tw3B |
Crystal structure of hiv-1 reverse transcriptase in complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)-4-fluorophenoxy)-7-fluoro-2-naphthonitrile (jlj636), a non-nucleoside inhibitor |
|
144
|
550
|
5tw3A |
Crystal structure of hiv-1 reverse transcriptase in complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)-4-fluorophenoxy)-7-fluoro-2-naphthonitrile (jlj636), a non-nucleoside inhibitor |
|
146
|
555
|
5tuqA |
Crystal structure of a 6-cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione inhibitor in complex with hiv reverse transcriptase |
|
100
|
424
|
5terB |
Crystal structure of hiv-1 reverse transcriptase in complex with 5-chloro-7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-8-methyl-2-naphthonitrile (jlj651), a non-nucleoside inhibitor |
|
142
|
554
|
5terA |
Crystal structure of hiv-1 reverse transcriptase in complex with 5-chloro-7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-8-methyl-2-naphthonitrile (jlj651), a non-nucleoside inhibitor |
|
109
|
424
|
5tuqB |
Crystal structure of a 6-cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione inhibitor in complex with hiv reverse transcriptase |
|
136
|
550
|
5tepA |
Crystal structure of hiv-1 reverse transcriptase in complex with 7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-2-naphthonitrile (jlj649), a non-nucleoside inhibitor |
|
102
|
424
|
5tepB |
Crystal structure of hiv-1 reverse transcriptase in complex with 7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-2-naphthonitrile (jlj649), a non-nucleoside inhibitor |
|
26
|
72
|
5teoA |
Dimer of hiv-1 gag ctd-sp1 fragment |
|
18
|
90
|
5t82A |
Hiv-1 reverse transcriptase thumb subdomain |
|
0
|
10
|
5t6zC |
Kir3dl1 in complex with hla-b*57:01-tw10 |
|
73
|
216
|
5t3aA |
Maedi-visna virus (mvv) integrase ccd-ctd (residues 60-275) |
|
103
|
428
|
5ovnB |
Crystal strucure of fiv reverse transcriptase |
|
113
|
532
|
5ovnA |
Crystal strucure of fiv reverse transcriptase |
|
43
|
152
|
5oi8A |
Dissociation of biochemical and antiretroviral activities of integrase-ledgf allosteric inhibitors revealed by resistance of a125 polymorphic hiv-1 |
|
40
|
152
|
5oi2A |
Dissociation of biochemical and antiretroviral activities of integrase-ledgf allosteric inhibitors revealed by resistance of a125 polymorphic hiv-1 |
|
41
|
152
|
5oi3A |
Dissociation of biochemical and antiretroviral activities of integrase-ledgf allosteric inhibitors revealed by resistance of a125 polymorphic hiv-1 |
|
43
|
152
|
5oiaA |
Dissociation of biochemical and antiretroviral activities of integrase-ledgf allosteric inhibitors revealed by resistance of a125 polymorphic hiv-1 |
|
44
|
152
|
5oi5A |
Dissociation of biochemical and antiretroviral activities of integrase-ledgf allosteric inhibitors revealed by resistance of a125 polymorphic hiv-1 |
|
151
|
537
|
5c24A |
Crystal structure of hiv-1 reverse transcriptase in complex with 7-((4-((4-cyanophenyl)amino)-1,3,5-triazin-2-yl)amino)-6,8-dimethylindolizine-2-carbonitrile (jlj605), a non-nucleoside inhibitor |
|
156
|
543
|
5k14A |
Hiv-1 reverse transcriptase in complex with a 2,6-difluorophenyl dapy analog |
|
111
|
424
|
5k14B |
Hiv-1 reverse transcriptase in complex with a 2,6-difluorophenyl dapy analog |
|
18
|
99
|
5kaoA |
Crystal structure of wild type hiv-1 protease in complex with grl-10413 |
|
19
|
99
|
5jg1A |
Hiv-1 wild type protease with grl-031-14a (a adamantane p1-ligand with tetrahydropyrano-tetrahydrofuran in p2 and isobutylamine in p1') |
|
52
|
154
|
5hrrA |
Hiv integrase catalytic domain containing f185k + a124n + t125s mutations complexed with gsk0002 |
|
161
|
554
|
5hbmA |
Crystal structure of a dihydroxycoumarin rnase h active-site inhibitor in complex with hiv-1 reverse transcriptase |
|
106
|
422
|
5fdlB |
Crystal structure of k103n/y181c mutant hiv-1 reverse transcriptase (rt) in complex with idx899 |
|
27
|
112
|
5fivA |
Structural studies of hiv and fiv proteases complexed with an efficient inhibitor of fiv pr |
|
144
|
554
|
5fdlA |
Crystal structure of k103n/y181c mutant hiv-1 reverse transcriptase (rt) in complex with idx899 |
|
48
|
153
|
5eu7A |
Crystal structure of hiv-1 integrase catalytic core in complex with fab |
|
18
|
99
|
5e5kA |
Joint x-ray/neutron structure of hiv-1 protease triple mutant (v32i,i47v,v82i) with darunavir at ph 4.3 |
|
18
|
99
|
5dgwA |
Crystal structure of hiv-1 protease inhibitor grl-105-11a containing substituted fused-tetrahydropyranyl tetrahydrofuran as p2-ligand |
|
18
|
99
|
5dguA |
Crystal structure of hiv-1 protease inhibitors containing substituted fused-tetrahydropyranyl tetrahydrofuran as p2-ligand grl-004-11a |
|
117
|
424
|
5cyqB |
Hiv-1 reverse transcriptase complexed with 4-bromopyrazole |
